A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/1997
10/02/1997	WO1997035854A1 Novel phenanthridines substituted in the 6 position
10/02/1997	WO1997035852A1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
10/02/1997	WO1997035849A1 1,2,4-triazine derivatives for the inhibition of protein glycosylation
10/02/1997	WO1997035581A1 Interleukin-6 production inhibitor
10/02/1997	WO1997035575A1 Use of rapamycin derivatives in vasculopathies and xenotransplantation
10/02/1997	WO1997035572A1 Carboxylic acid indole inhibitors of chemokines
10/02/1997	WO1997035567A1 Pla2 inhibitors of angiogenesis
10/02/1997	WO1997035538A2 Tumor necrosis factor alpha convertase
10/02/1997	WO1997026331A3 Use of neuronal apoptosis inhibitor protein (naip)
10/02/1997	WO1997024111A3 Novel hyaluronic acid receptors binding agents and the use thereof
10/02/1997	WO1997023611A3 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/02/1997	DE19654895A1 Quantitative determination of endothelial dysfunction in mammals
10/02/1997	DE19612645A1 Dimethyl-substituierte Cyclohexandienderivate Dimethyl-substituted Cyclohexandienderivate
10/02/1997	CA2251691A1 Peptides with antiproliferative properties
10/02/1997	CA2250576A1 Monocyte chemotactic protein-5 materials and methods
10/02/1997	CA2250099A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases
10/02/1997	CA2249999A1 1,2,4-triazine derivatives for the inhibition of protein glycosylation
10/02/1997	CA2249985A1 Tumour necrosis factor alpha convertase
10/01/1997	EP0798298A1 Thiazolidinone compounds or angina pectoris remedy or preventive containing the same as active ingredient
10/01/1997	EP0798002A1 Inhibition of vascular stenosis
10/01/1997	EP0797993A1 Compostions comprising l-carnitine or derivatives thereof and antioxidants
10/01/1997	EP0797992A2 Use of taurine, homotaurine and/or methionine for inducing analgesia or anesthesia and treating or preventing ischaemic injury
10/01/1997	EP0797988A2 Anti-angiogenic compositions and methods of use
10/01/1997	EP0797591A1 A novel chemokine expressed in inflamed adenoid, its production and uses
10/01/1997	EP0797575A1 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
10/01/1997	EP0797439A1 Use of pramipexole as a neuroprotective agent
10/01/1997	EP0596015B1 Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof
10/01/1997	CN1161041A Heterocycle-condensed morphinoid derivatives
10/01/1997	CN1161035A Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
10/01/1997	CN1160716A New compounds derived from boronic acid, process for their preparation and pharmaceutical compositions containing them
09/1997
09/30/1997	US5672705 Antiischemic agents treating nervous system disorders, huntington' disease, alzheimer's disease, parkinson's disease
09/30/1997	US5672618 Protein kinase C inhibitors
09/30/1997	US5672599 Compounds containing a fused bicycle ring
09/30/1997	US5672587 Isoproterenol prodrug with reduced side effects
09/30/1997	US5672584 Modified with end groups
09/30/1997	US5672583 Carboxy-peptidyl derivatives as antidegenerative active agents
09/30/1997	US5672508 Polypeptide comprising cyclin dependent kinase binding motifs from two or more proteins
09/30/1997	US5672356 Bioadhesive pharmaceutical composition for the controlled release of active principles
09/25/1997	WO1997035024A1 Enzyme combinations for destroying proliferative cells
09/25/1997	WO1997034901A1 Piperidine derivatives
09/25/1997	WO1997034900A1 Azaspiro derivatives
09/25/1997	WO1997034885A1 Benzopyran derivatives having leukotriene-antagonistic action
09/25/1997	WO1997034883A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
09/25/1997	WO1997034876A1 Cinnoline derivatives and use as medicine
09/25/1997	WO1997034597A1 Use of antiarrhythmic compounds for reducing post-infarction mortality
09/25/1997	WO1997026867A3 Solid instant-release forms of administration and process for producing the same
09/25/1997	CA2250016A1 Piperidine derivatives
09/25/1997	CA2249481A1 Use of antiarrhythmic compounds for reducing post-infarction mortality
09/25/1997	CA2248629A1 Enzymes combinations for destroying proliferative cells
09/25/1997	CA2247940A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
09/24/1997	EP0796864A2 Steroidal glycosides for treating hypercholesterolemia
09/24/1997	EP0796863A2 Steroidal glycosides for treating hypercholesterolemia
09/24/1997	EP0796862A2 Steriodal glycosides for treating hypercholesterolemia
09/24/1997	EP0796855A1 Inhibitors of bone resorption and vitronectin receptor antagonists
09/24/1997	EP0796854A1 Benzopyran derivative and use of said benzopyran derivative for treating heart disease
09/24/1997	EP0796846A1 2-Aryl substituted pyridines
09/24/1997	EP0796617A1 Use of antiarhythmic compounds to reduce post-infarct mortality
09/24/1997	EP0796330A1 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
09/24/1997	EP0796322A1 Production and use of human and plant methyltransferases
09/24/1997	EP0796270A2 Peptide compounds for prevention and/or treatment of no-mediated diseases
09/24/1997	EP0796260A1 Rapamycin 42-oximes and hydroxylamines
09/24/1997	EP0796251A1 Uracil derivatives
09/24/1997	EP0796250A1 Pyridazinones as endothelin-receptor antagonists
09/24/1997	EP0796109A1 Antisense oligonucleotides to suppress eicosanoid formation
09/24/1997	EP0796099A1 Use of xanthine oxidase inhibitors as anti-ischaemic agents
09/24/1997	EP0696280B1 Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
09/24/1997	EP0636143B1 Alpha-aminoboronic acid peptides and their use as elastase inhibitors
09/24/1997	EP0491708B1 Isolating aminoarginine and use to block nitric oxide formation in body
09/24/1997	CN1160397A Azole deriv.
09/24/1997	CN1160396A Carboxylic acid derivs., their preparation and their use
09/24/1997	CN1160042A Ortho-substd. benzoyl guanidines, their preparing process and use as medicine and diagnostic reagent, and medicine contg. same
09/24/1997	CN1160041A Ortho-substd. benzoyl guanidines, their preparing process and use as medicine and diagnostic reagent, and medicine contg. same
09/24/1997	CN1159950A Bioadhesive pharmaceutical composition for controlled release of active principles
09/24/1997	CN1159945A 丹藤治栓丸 Tando rule bolt pill
09/24/1997	CN1035944C Method for preparing 3-aminopiperidine derivs. and related nitrogen-contg. heterocycles
09/24/1997	CN1035925C Method for preparation of cytotropic non-homogeneous molecular lipid
09/23/1997	US5670699 Process for preparing amino acid esters useful as intermediates for compounds containing a fused bicyclic ring
09/23/1997	US5670545 Cardiovascular disorders
09/23/1997	US5670544 Substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicament containing them
09/23/1997	US5670527 Cytokine inhibitors useful in treating asthma, osteoporosis, arthritis, inflammation, sepsis, cardiovascular disorders, diabetes, multiple sclerosis, skin disorders
09/23/1997	US5670525 Substituted 4-phenyl-6-amino-nicotinic acid compounds useful in the treatment of CNS disorders
09/23/1997	US5670516 Excitatory amino acid receptor antagonists
09/23/1997	US5670505 Tachykikin antagonist for respiratory diseases, ophthalmic diseases and antiinflammatory agents
09/23/1997	US5670504 2,6-diaryl pyridazinones with immunosuppressant activity
09/23/1997	US5670501 Useful as diuretics, treating renal disorders, restoring cardiac functions
09/23/1997	US5670499 Physiological disorders, gastrointestinal disorders, antiinflammatory agents
09/23/1997	US5670482 Neuropeptide Y antagonists
09/23/1997	US5670177 Injectable NO/CO2 gaseous mixture
09/23/1997	US5670172 Pharmaceutical spheroid formulation
09/20/1997	CA2200175A1 2-aryl-substituted pyridines
09/20/1997	CA2199923A1 Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors
09/18/1997	WO1997034137A2 Methods of the identification of pharmaceutically active compounds
09/18/1997	WO1997033996A2 Human bikunin
09/18/1997	WO1997033995A2 Extracellular matrix signalling molecules
09/18/1997	WO1997033911A1 Persephin and related growth factors
09/18/1997	WO1997033902A1 Human tumor necrosis factor delta and epsilon
09/18/1997	WO1997033901A1 Smooth muscle cell lim protein
09/18/1997	WO1997033887A1 Spirocycle integrin inhibitors
09/18/1997	WO1997033883A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases
09/18/1997	WO1997033882A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake

1 ... 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 ... 1595